How is rybelsus used for weight loss?
Obesity is a growing problem in the United Kingdom and is one of the greatest long-term health challenges currently faced in England. Around two-thirds (63%) of adults are above a healthy weight and half are living with obesity.
Obesity is associated with a number of chronic diseases, including heart disease, the risk of heart attack, stroke, Type 2 diabetes, cancer and osteoarthritis. It also increases the chances of developing high blood pressure, sleep apnea and other breathing problems, gallstones or fatty liver disease.
If you’re looking to lose weight, you may have heard of the diabetes prescription drug called Rybelsus. But how can a diabetes drug help with weight loss? It is also being studied as an aid for weight loss in people who are obese or overweight but do not have diabetes. Some doctors may prescribe Rybelsus “off-label” for weight loss. By understanding what Rybelsus is and how it works, you can decide whether this drug is right for you. Let’s take a look at what Rybelsus is and how it can help with weight loss.
What is Rybelsus?
Rybelsus is the brand name of the active ingredient semaglutide and is manufactured by Novo Nordisk. It is an oral diabetes medication used to treat type 2 diabetes mellitus, it also helps to reduce the risk of severe cardiovascular events. It is not used to treat type 1 diabetes.
Rybelsus belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists or GLP-1 inhibitors, which increase insulin production in the body when glucose levels become too high. This helps control blood sugar levels, reducing your risk of developing diabetes-related complications such as kidney disease or stroke.
How Does Rybelsus Work?
Diabetes
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist designed to help control blood glucose levels for those with type 2 diabetes. This medicine works by signalling the liver to slow the production and release of excess sugar from stored food sources, this helps maintain normal blood glucose levels after meals.
Weight management
Semaglutide can help with weight loss by reducing hunger and increasing feelings of fullness. It works by acting on the brain’s satiety centre, which activates hormones that suppress the feeling of hunger and create a longer-lasting feeling of fullness after meals. This hormone is also responsible for increasing metabolism, which helps to burn more calories throughout the day, leading to greater weight loss.
Does Rybelsus cause weight loss?
Rybelsus has been shown to be effective in aiding reductions in body weight. In a one-year clinical trial, those taking Rybelsus (14 mg dose, which is the higher dose) lost an average of 4.4 kilograms or about 10 pounds, even with metformin treatment for type 2 diabetes already established.
A separate comparison between Rybelsus and liraglutide showed that the former was more successful in promoting substantial weight reduction than its counterpart injection medication.
However, it is important to note that while semaglutide may help contribute to weight loss goals when taken along with diet and exercise, patients saw even greater improvements in their overall health, including lower cholesterol and improved glucose control.
Can Rybelsus be used for weight loss in non-diabetics?
While Rybelsus is not yet approved as a weight loss drug for those without diabetes, Wegovy and Saxenda are GLP-1 receptor agonists that have been granted the green light as weight loss medication. These injectables can provide non-diabetics an effective means to reach their health and fitness goals when used with lifestyle changes.
If your prescribing doctor determines it is safe and medically appropriate, it is possible that Rybelesus can be prescribed off-label for weight management if deemed medically appropriate. It is prescribed off-label for those with a body mass index (BMI) of 30 and over with at least one weight-related issue, such as high blood pressure. It must be taken alongside a healthy diet and exercise regime to see the full benefits.
How do I take Rybelsus?
To maximise its effectiveness, take one Rybelsus tablet daily on an empty stomach and at least 30 minutes before consuming the first meal or drink of the day, usually in the morning. Be sure not to crush, split or chew tablets, as this can reduce absorption. If you miss a dose, skip it and continue with your regular schedule; however, if after 12 weeks, treatment has resulted in less than 5% initial body weight loss, your doctor may recommend discontinuing its use.
What dosages of Rybelsus are available?
Rybelsus is designed to be taken in doses of 3mg, 7mg and 14 mg, respectively. To help you achieve healthy weight loss with lasting effects, your doctor will gradually increase the dosage over time, beginning at 3mg per day. After one month on that dose if deemed suitable by your physician, it may move up to the next level of 7 mg for another steadying period, before potentially increasing again but never higher than 14mg every 24 hours. Never exceed 14 mg dose per day or follow instructions from anyone other than a healthcare provider.
What are the common side effects of Rybelsus?
Common possible side effects include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Headaches
- Abdominal pain
- Fatigue
Taking Rybelsus on an empty stomach can help with some of its side effects, so follow your recommended dosage instructions carefully.
What are the serious side effects of Rybelsus?
- An increased risk of heart attack and stroke
- Low blood sugar (hypoglycemia) is more common if taken with insulin or a sulfonylurea
- Kidney problems
- Diabetic retinopathy
- Inflammation of the pancreas (pancreatitis)
- A lump or swelling in your neck (potential thyroid cancer/tumours)
- Severe allergic reactions such as hives or swelling of the face or throat after taking the medication
There may be risks associated with taking Rybelsus that need to be thoroughly discussed by you and your doctor before beginning treatment. If you experience any of these symptoms while taking Rybelsus, you should immediately seek medical attention.
Patients not suitable for Rybelsus
Rybelsus, the first-ever oral glucagon-like peptide 1 (GLP-1) receptor agonist medication available on the market, is an effective treatment option for Type 2 diabetes. However, it is important to note that Rybelsus is not recommended for certain groups of patients:
- Patients with diabetic ketoacidosis
- Patients with type 1 diabetes
- Patients below the age of 18
- Patients with severe renal or liver impairment
- Patients with a personal or family history of medullary thyroid carcinoma (MTC)
- Patients with a rare genetic condition called multiple endocrine neoplasia syndrome type 2
- Those who are allergic to any of the ingredients in the medication
- Pregnant women and breastfeeding mothers
Furthermore, risks may be associated with consuming Rybelsus with other medications, so make sure your healthcare provider knows about all your medications and supplements. It’s also important to check whether Rybelsus is safe to use if you have other conditions besides type 2 diabetes. By talking to your healthcare provider and knowing which patients should avoid taking the medication, you can ensure that your treatment is safe and effective.
Is Ozempic the same as Rybelsus?
Rybelsus and Ozempic both contain the same active ingredient, semaglutide. Both medications are used to treat type 2 diabetes and can also be prescribed ‘off-label’ for weight management. The key difference between these treatments lies in the way they’re taken: Rybelsus is an oral tablet, while Ozempic needs to be injected into fatty tissue areas like your arm or leg. Rybelsus provides a suitable alternative medication option for those who have difficulty with injections.
Talk to your healthcare professional
Rybelsus may not be suitable for you if you have certain medical conditions, take specific prescriptions, over-the-counter medications or other factors affecting your health. Before starting on any new medications or dietary supplements, discuss them with your healthcare professional first. Your doctor will be able to provide you with personalised advice tailored to your own unique needs and lifestyle. Additionally, if you experience any side effects when taking Rybelsus, such as nausea or stomach pain, speak with your doctor immediately so they can adjust the dosage or recommend an alternative option if necessary.
Rybelsus is an NHS approved treatment for adults, but with a side effect of weight loss, many people are curious if it can help them. The NHS don’t recommend taking medication like Rybelsus just for the purpose of losing weight. While it may positively affect body composition, it was made to help control blood sugar levels and should not be taken without first speaking to an NHS GP or Nurse. Suppose you are interested in using an NHS-approved treatment specifically designed for weight loss. In that case, there are several lifestyle and diet changes that an NHS Healthcare Practitioner would be able to suggest.
Sources
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes – NIH
- Obesity Profile update: July 2022 – Gov UK
- Obesity Treatment – NHS
- Package leaflet: Information for the patient – Medicines
- RYBELSUS lowered blood sugar better than a leading branded pill – Rybelus
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111